TSX: ACB
EDMONTON, Feb. 12, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced
that the Company has granted a total of 150,000 options to a
director of the Company, exercisable at $11.53 per common share. The options shall vest
quarterly over a period of 36 months and shall expire 5 years
following the date of granting.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). Aurora operates a 55,200 square foot production
facility in Mountain View County, Alberta, known as "Aurora Mountain", a 40,000
square foot production facility known as "Aurora Vie" in
Pointe-Claire, Quebec, and an
800,000 square foot production facility, known as "Aurora Sky", at
the Edmonton International
Airport. Aurora is also completing a fourth facility of 48,000
square feet in Lachute, Quebec,
and will shortly begin construction on a 1,000,000 square foot
production facility in Odense,
Denmark, to be known as "Aurora Nordic", via a joint venture
with Alfred Pedersen & Søn
ApS.
Aurora also owns Berlin-based
Pedanios GmbH, the leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union. Aurora
offers further differentiation through its wholly owned
subsidiaries BC Northern Lights Ltd. and Urban Cultivator Inc.,
industry leaders, respectively, in the production and sale of
proprietary systems for the safe, efficient and high-yield indoor
cultivation of cannabis, and in state-of-the-art indoor gardening
appliances for the cultivation of organic microgreens, vegetables
and herbs in home and professional kitchens.
In addition, Aurora holds approximately 17.23% of the issued
shares in leading extraction technology company Radient
Technologies Inc., and has a strategic investment in Hempco Food
and Fiber Inc., with options to increase ownership stake to over
50%. Aurora is also the cornerstone investor in two other licensed
producers, with a 22.9% stake in Cann Group Limited, the first
Australian company licensed to conduct research on and cultivate
medical cannabis, and a 17.62% stake in Canadian producer The Green
Organic Dutchman Ltd., with options to increase to majority
ownership.
On behalf of the Boards of
Directors,
AURORA CANNABIS INC.
Terry Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX, nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accept
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.